OSBPL9 antibody
Principal name
OSBPL9 antibody
Alternative names for OSBPL9 antibody
OSBP-related protein 9, ORP-9, ORP9, OSBP4, Oxysterol-binding protein-related protein 9
Ncbi ID
9606, NP_683702, NP_078862, NM_148904, NM_148905, NM_148906, NM_148907, NM_148908, NM_148909, NP_683707, NP_683706, NP_683705, NP_683703, NP_078862.4, NP_775485.2, NM_133885, NM_001134791, NM_173350, NM_024586
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of OSBPL9 antibody
The OSBPL9 gene encodes a member of the oxysterol-binding protein (OSBP) family, a group of intracellular lipid receptors. Most members contain an N-terminal pleckstrin homology domain and a highly conserved C-terminal OSBP-like sterol-binding domain, although some members contain only the sterol-binding domain. OSBPL9 appears to be in a distinct OSBP subfamily and shares relatively little homology in the sterol-binding domain with other OSBPs. Multiple transcript variants have been identified, most of which encode distinct isoforms.
This gene encodes a member of the oxysterol-binding protein (OSBP) family, a group of intracellular lipid receptors. Most members contain an N-terminal pleckstrin homology domain and a highly conserved C-terminal OSBP-like sterol-binding domain, although some members contain only the sterol-binding domain. Multiple transcript variants, most of which encode distinct isoforms, have been identified.
General readings
Lehto M, Laitinen S, Chinetti G, Johansson M, Ehnholm C, Staels B, Ikonen E, Olkkonen VM. The OSBP-related protein family in humans. J Lipid Res. 2001 Aug;42(8):1203-13.




Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA311524 | OSBPL9 (C-term) antibody |
||||||
| Goat Anti-ORP9 / OSBPL9 Antibody | |||||||
![]() |
Goat | Aff - Purified | Bov, Can, Hu, Ms | E, P |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| AP22570PU-N | OSBPL9 (735-746) antibody |
||||||
![]() |
Goat | Aff - Purified | Bov, Bt, Can, Elephant, Eq, Hu, Mky, Rb | E, P |
50 µg /
€425.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP311520 | OSBPL9 (transcript variant 7) |
||||
| Recombinant protein of human oxysterol binding protein-like 9 (OSBPL9), transcript variant 7 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP321053 | OSBPL9 (transcript variant 5) |
||||
| Recombinant protein of human oxysterol binding protein-like 9 (OSBPL9), transcript variant 5 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP321526 | OSBPL9 (transcript variant 4) |
||||
| Recombinant protein of human oxysterol binding protein-like 9 (OSBPL9), transcript variant 4 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP760439 | OSBPL9 (full length, N-term HIS tag, transcript variant 2) |
||||
| Purified recombinant protein of Human oxysterol binding protein-like 9 (OSBPL9), transcript variant 2, full length, with N-terminal HIS tag, expressed in E.Coli, 50ug | |||||
![]() |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
| TP760538 | OSBPL9 (N-term HIS tag, transcript variant 1) |
||||
| Purified recombinant protein of Human oxysterol binding protein-like 9 (OSBPL9), transcript variant 1, with N-terminal HIS tag, expressed in E.Coli, 50ug | |||||
![]() |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY407760 | OSBPL9 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY407761 | OSBPL9 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY407762 | OSBPL9 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY407763 | OSBPL9 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY407764 | OSBPL9 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY407765 | OSBPL9 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY430195 | OSBPL9 overexpression lysate |
|
![]() |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY430196 | OSBPL9 overexpression lysate |
|
![]() |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY430197 | OSBPL9 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY430198 | OSBPL9 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC221053L1V | Lenti ORF particles, OSBPL9 (Myc-DDK tagged) - Human oxysterol binding protein-like 9 (OSBPL9), transcript variant 5 , 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,530.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR208847L2V | Lenti ORF particles, Osbpl9 (GFP-tagged) - Mouse oxysterol binding protein-like 9 (Osbpl9), transcript variant a, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,530.00
|
|
| OriGene Technologies, Inc. | ||
| MR208847L1V | Lenti ORF particles, Osbpl9 (Myc-DDK-tagged) - Mouse oxysterol binding protein-like 9 (Osbpl9), transcript variant a, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,370.00
|
|
| OriGene Technologies, Inc. | ||








+1 additional image




